Genetic variations ensure no two people or their cancers are identical, and researchers may provide more precise and effective treatment wielding tools and knowledge that predict how individuals will respond to cancer therapy.
Read MoreImmunoCellular Therapeutics Ltd, Los Angeles has completed the acquisition of monoclonal antibody related technology owned by Molecular Discoveries LLC, NY.
Read More
HTRF KinEase Combines monoclonal antibody with HTRF technology Cisbio International, Céze, France, a global developer of HTRF technology and services used in assay development and drug screening, launches HTRF KinEASE TK, a universal, sensi
Read More
Lung and breast cancer, Alzheimer’s, and conestive heart failure tests are in the forefront of development.
Read MoreDxS, Manchester, UK, has been awarded a Biotechnology Project of the Year award for its Epidermal Growth Factor Receptor Mutation Test Kit.
Read More